S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Alibaba Stock Analysis: Insights, Trends, and Future Predictions
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Alibaba Stock Analysis: Insights, Trends, and Future Predictions
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Alibaba Stock Analysis: Insights, Trends, and Future Predictions
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
3 Magnificent Seven Stocks Outperforming the Rest
Alibaba Stock Analysis: Insights, Trends, and Future Predictions
NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0006
$0.0006
50-Day Range
$2.20
$4.34
52-Week Range
$1.62
$10.97
Volume
55 shs
Average Volume
271,922 shs
Market Capitalization
$9,287.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CBLI stock logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Cytocom, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.

CBLI Stock News Headlines

Cleveland Construction News
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Cleveland Manufacturing News
Cleveland Commercial Real Estate News
Cleveland, TN
Cleveland News
5 Stocks Under $5 Making Big Moves
Cleveland BioLabs Gets Orphan Status for Entolimod in EU
Statera Biopharma Inc
Statera BioPharma: The Ticker Formerly Known as CBLI
Cytocom to rename as Statera BioPharma
See More Headlines
Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2020
Today
4/20/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
Fax
N/A
Employees
4
Year Founded
2003

Profitability

Net Income
$-2,400,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$260,000.00
Book Value
$0.87 per share

Miscellaneous

Free Float
N/A
Market Cap
$9,287.40
Optionable
Not Optionable
Beta
0.70

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Michael Kevin Handley
    President, Chief Executive Officer & Director
  • Taunia S. Markvicka
    Chief Operating Officer & Director
  • Peter J. Aronstam
    Chief Financial Officer
  • Andrei V. Gudkov
    Global Head-Research & Development
  • Clifford A. Selsky
    Chief Medical Officer

CBLI Stock Analysis - Frequently Asked Questions

How were Cleveland BioLabs' earnings last quarter?

Cleveland BioLabs, Inc. (NASDAQ:CBLI) released its quarterly earnings results on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share for the quarter. The biotechnology company earned $0.16 million during the quarter.

What other stocks do shareholders of Cleveland BioLabs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cleveland BioLabs investors own include iBio (IBIO), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Tonix Pharmaceuticals (TNXP), Dynavax Technologies (DVAX), Gilead Sciences (GILD), Novavax (NVAX), Biocept (BIOC) and Co-Diagnostics (CODX).

This page (NASDAQ:CBLI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners